Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells

The interaction of activated Ras with Raf initiates signaling cascades that contribute to a significant percentage of human tumors, suggesting that agents that specifically disrupt this interaction might have desirable chemotherapeutic properties. We used a subtractive forward two-hybrid approach to identify small molecule compounds that block the interaction of Ras with Raf. These compounds (MCP1 and its derivatives, 53 and 110) reduced serum-induced transcriptional activation of serum response element as well as Ras-induced transcription by way of the AP-1 site. They also inhibited Ras-induced Raf-1 activation in human embryonic kidney 293 cells, Raf-1 and mitogen-activated protein kinase kinase 1 activities in HT1080 fibrosarcoma cells, and epidermal growth factor-induced Raf-1 activation in A549 lung carcinoma cells. The MCP compounds caused reversion of ras-transformed phenotypes including morphology, in vitro invasiveness, and anchorage-independent growth of HT1080 cells. Decreased level of matrix metalloproteinases was also observed. Further characterization showed that MCP compounds restore actin stress fibers and cause flat reversion in NIH 3T3 cells transformed with H-Ras (V12) but not in NIH 3T3 cells transformed with constitutively active Raf-1 (RafΔN). Finally, we show that MCP compounds inhibit anchorage-independent growth of A549 and PANC-1 cells harboring K-ras mutation. Furthermore, MCP110 caused G1 enrichment of A549 cells with the decrease of cyclin D level. These results highlight potent and specific effects of MCP compounds on cancer cells with intrinsic Ras activation.

[1]  K. Inouye,et al.  Formation of the Ras Dimer Is Essential for Raf-1 Activation* , 2000, The Journal of Biological Chemistry.

[2]  M. Marshall,et al.  In vitro inhibition of Ras-Raf association by short peptides. , 1998, Biochemical and biophysical research communications.

[3]  N. Tusneem,et al.  Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles , 1996, Molecular and cellular biology.

[4]  T. Kataoka,et al.  Epidermal growth factor stimulation of the ACK1/Dbl pathway in a Cdc42 and Grb2-dependent manner. , 2001, Biochemical and biophysical research communications.

[5]  C. Der,et al.  The Ras branch of small GTPases: Ras family members don't fall far from the tree. , 2000, Current opinion in cell biology.

[6]  W. R. Bishop,et al.  Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the Microtubules* , 2000, The Journal of Biological Chemistry.

[7]  S. Sebti,et al.  The Farnesyltransferase Inhibitor, FTI-2153, Blocks Bipolar Spindle Formation and Chromosome Alignment and Causes Prometaphase Accumulation during Mitosis of Human Lung Cancer Cells* , 2001, The Journal of Biological Chemistry.

[8]  E. Nishida,et al.  cDNA cloning of MAP kinase kinase reveals kinase cascade pathways in yeasts to vertebrates. , 1993, The EMBO journal.

[9]  D. Bar-Sagi.  A Ras by Any Other Name , 2001, Molecular and Cellular Biology.

[10]  W. R. Bishop,et al.  The farnesyl transferase inhibitor SCH 66336 induces a G(2) --> M or G(1) pause in sensitive human tumor cell lines. , 2001, Experimental cell research.

[11]  J. McCubrey,et al.  The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors. , 2000, Pharmacology & therapeutics.

[12]  D. Helfman,et al.  Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts. , 2002 .

[13]  M. Zegers,et al.  Induced Expression of Rnd3 Is Associated with Transformation of Polarized Epithelial Cells by the Raf–MEK–Extracellular Signal-Regulated Kinase Pathway , 2000, Molecular and Cellular Biology.

[14]  A. Goffeau,et al.  The pleitropic drug ABC transporters from Saccharomyces cerevisiae. , 2001, Journal of molecular microbiology and biotechnology.

[15]  F. Tamanoi,et al.  Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells , 2001, Cellular and Molecular Life Sciences CMLS.

[16]  N. Rosen,et al.  A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. , 1995, Cancer research.

[17]  G. Bollag,et al.  Discovery of a novel Raf kinase inhibitor. , 2001, Endocrine-related cancer.

[18]  C. Jacq,et al.  Multiple-drug-resistance phenomenon in the yeast Saccharomyces cerevisiae: involvement of two hexose transporters , 1997, Molecular and cellular biology.

[19]  Erica A. Golemis,et al.  Analysis of the Interaction of the Novel RNA Polymerase II (pol II) Subunit hsRPB4 with Its Partner hsRPB7 and with pol II , 1998, Molecular and Cellular Biology.

[20]  J. Troppmair,et al.  Independent control of cell survival by Raf-1 and Bcl-2 at the mitochondria , 2001, Oncogene.

[21]  V. Stanton,et al.  Definition of the human raf amino-terminal regulatory region by deletion mutagenesis , 1989, Molecular and cellular biology.

[22]  C. Der,et al.  Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells , 1999, Oncogene.

[23]  C. Marshall,et al.  Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells , 1987, Cell.

[24]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[25]  S. Yokoyama,et al.  Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation. , 2002, European journal of biochemistry.

[26]  G. Bepler,et al.  Epidermal growth factor receptor expression in human lung cancer cell lines. , 1988, Cancer research.

[27]  W. R. Bishop,et al.  K- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase Inhibitors* , 1997, The Journal of Biological Chemistry.

[28]  E. Golemis,et al.  A Two-hybrid Dual Bait System to Discriminate Specificity of Protein Interactions* , 1999, The Journal of Biological Chemistry.

[29]  M. J. Arboleda,et al.  Dominant negative mutants of mitogen-activated protein kinase pathway. , 2001, Methods in enzymology.

[30]  A. Pawson,et al.  Proliferation of human malignant astrocytomas is dependent on Ras activation , 1997, Oncogene.

[31]  C. Der,et al.  Dissection of Ras-Dependent Signaling Pathways Controlling Aggressive Tumor Growth of Human Fibrosarcoma Cells: Evidence for a Potential Novel Pathway , 2000, Molecular and Cellular Biology.

[32]  R. Muschel,et al.  Ras, metastasis, and matrix metalloproteinase 9. , 2001, Methods in enzymology.

[33]  D. Lowy,et al.  Function and regulation of ras. , 1993, Annual review of biochemistry.

[34]  F. Tamanoi,et al.  Farnesyltransferase inhibitors induce dramatic morphological changes of KNRK cells that are blocked by microtubule interfering agents. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. Irie,et al.  Radicicol Leads to Selective Depletion of Raf Kinase and Disrupts K-Ras-activated Aberrant Signaling Pathway* , 1998, The Journal of Biological Chemistry.

[36]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[37]  J. Sedivy,et al.  Raf-1 protein kinase activates the NF-kappa B transcription factor by dissociating the cytoplasmic NF-kappa B-I kappa B complex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Der,et al.  Understanding Ras: 'it ain't over 'til it's over'. , 2000, Trends in cell biology.

[39]  E. Golemis,et al.  Two-hybrid dual bait system to discriminate specificity of protein interactions in small GTPases. , 2001, Methods in enzymology.

[40]  David Botstein,et al.  RERG Is a Novel ras-related, Estrogen-regulated and Growth-inhibitory Gene in Breast Cancer* , 2001, The Journal of Biological Chemistry.

[41]  Jing Chen,et al.  Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK–ERK independent mechanism , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Morrison,et al.  The complexity of Raf-1 regulation. , 1997, Current opinion in cell biology.

[43]  Richard Treisman,et al.  Functional analysis of a growth factor-responsive transcription factor complex , 1993, Cell.

[44]  C. Marshall,et al.  How do small GTPase signal transduction pathways regulate cell cycle entry? , 1999, Current opinion in cell biology.

[45]  F. Gorelick,et al.  Pancreas Cell Physiology and Pancreatitis Cell Biology , 2003, Pancreatology.

[46]  S. Chellappan,et al.  Raf-1 Physically Interacts with Rb and Regulates Its Function: a Link between Mitogenic Signaling and Cell Cycle Regulation , 1998, Molecular and Cellular Biology.